Primer: Fujian Haixi Pharmaceuticals (2637 HK) - Aug 2026
Fujian Haixi Pharmaceuticals is a high-growth, commercial-stage company successfully leveraging stable revenue from its generic drug portfolio...
86 Views
𝛼SK or SearchENTITY
Fujian Haixi Pharmaceuticals (2637 HK)
Fujian Haixi Pharmaceuticals (2637 HK)
8
Analysis
Health Care • China
Fujian Haixi Pharmaceuticals is a commercial-stage innovative pharmaceutical company that researches, develops, produces, and sells both generic and innovative drugs. Its product portfolio includes generic drugs for various therapeutic areas and innovative drug candidates for retinal diseases and oncology. The company was founded in 2012 and is headquartered in Fuzhou, Fujian Province, China.
morex